An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a ...

CDC's RSV vaccine recommendations from Pfizer and GSK face review by HHS advisor William "Reyn" Archer III. Read more here.

Robert F. Kennedy Jr.'s aide seeks further data on CDC panel's recommendations for vaccines, reflecting Kennedy's skepticism ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

Of the RSV patients aged 60 or older, 23.0% were admitted to an ICU, 31.5% had acute organ failure, and 9.8% received IMV or ...

There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra ...

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...